| # | Filing Date | Period End Date | Type | Report Link | 
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating | 
|---|
																	
																	Lake Street analyst Ben Klieve maintains Bioceres Crop Solutions (NASDAQ:BIOX) with a Buy and lowers the price target from $...
																	
																	Canaccord Genuity analyst Austin Moeller downgrades Bioceres Crop Solutions (NASDAQ:BIOX) from Buy to Hold and lowers the pr...
																	
																	Bioceres Crop Solutions (NASDAQ:BIOX) reported quarterly losses of $(0.76) per share which missed the analyst consensus estimat...